Category: Hiring/layoffs
-
From Freelancer to Business Owner: The Challenges of Growing Your Freelance Venture
Growing your freelancing venture means scaling your workload and taking on new responsibilities.
-
Infographic – China, India Continue as Top Student Sources
China and India provided more than half of all international students at U.S. universities in the last academic year, as total enrollment from overseas approached pre-pandemic levels.
-
Safeguarding Your Business: A Comprehensive Guide
Protecting your business requires taking several measures that cover physical security, digital asset protection and legal compliance.
-
Grant Funds Typhoid Vaccine Patch Development
A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device.
-
Building Team Identity: The Role of Lanyards and More
One often overlooked yet effective tool for building team identity is the humble lanyard, but its significance goes beyond its practical use.
-
Infographic – Tech Layoffs Decline This Year
Employment in the technology industry is becoming more stable as layoffs by tech companies overall have steadily declined since the start of 2023.
-
Infographic – Top A.I. Work Impact Expected in Financial Services
Generative artificial intelligence is expected to affect more work processes in banking and insurance than other industries, according to a recent study.
-
Infographic – Major A.I. Work Impact Expected
22 Apr. 2023. In a recent poll, most Americans expect artificial intelligence to have a major impact on the conduct of work in the next 20 years, but not their own work. Pew Research Center released the findings of the survey on Thursday 20 Apr., conducted in Dec. 2022 among adults in the U.S. The…
-
Infographic – Tech Layoffs Jump This Year
Since the start of 2023, layoffs in technology industries worldwide rose markedly, continuing a trend that began in the fall of 2022.
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.